-
interact and communicate with external customers to value sell Henkel's adhesives. Supports R&D projects critical to business as well as road mapping of technology/business development. Generates test plans
-
their pre-clinical therapeutics in-vitro and in-vivo needs. This individual will work in the area of therapeutic protein production and engineering in mammalian cells. The individual will perform
-
at the center of our operations and you'll find that everything we do, every day, is in line with an unwavering commitment to quality. A Senior Associate Scientist in Analytical Technology and Compound Management
-
National Institutes of Health/National Library of Medicine | Bethesda, Maryland | United States | about 1 month ago
STAFF SCIENTIST 1 - Human Regulatory Genomics Position Information: The National Library of Medicine (NLM) is one of 27 Institutes and Centers at the National Institutes of Health. NLM is a global
-
A Staff Scientist 1 position is available in the Retinal Development, Genetics and Therapy Section within the Neurobiology, Neurodegeneration, & Repair Laboratory (NNRL) under the supervision of Dr. Anand Swaroop. A major goal of the Swaroop laboratory is to elucidate gene/genomic regulation in...
-
cutting edge design and process development capabilities to accelerate and bring the best in class medicines to patients around the world. POSITION SUMMARY We are seeking a chemical engineer/chemist to join
-
of the Oncogenic Transcriptional Networks Group within the Cancer Cell Biology (CCB) Department. The candidate should have expertise in cell line engineering technologies, molecular and protein biology methods, and
-
or her accomplishments and abilities. Promotion on this track will be based on achievement of goals. Minimum Qualifications PhD in physics, engineering, medical physics, or biomedical imaging strongly
-
MS in Chemistry, Chemical Engineering or related field, 2-5 years experience working in formulations lab and performing quality testing procedures. Project management experience is preferred. Must have
-
development for degenerative retinal disease. We employ multidisciplinary approaches, including engineered mice, human pluripotent stem cells, organoids, CUT&RUN, CRISPR gene editing, bulk and single-cell RNA